Good day, everyone. Welcome to today's Conference Call to discuss BD's First Quarter Fiscal 2025 Earnings and BD's announcement of its Intent to Separate BD's Biosciences and Diagnostic Solutions ...
After a tumultous few years, Becton, Dickinson is undergoing course correction. The COVID-19 revenue windfall has been reinvested, which should lift the firm's core business growth in the upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results